Almena Free, MD
Internal Medicine · Anniston, ALNPI 1144244070
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Johnson & Johnson at 35.5% of the total. Reporting peaked in 2023 at $215 and has fallen 85.6% since, to $31 in 2024.
Across 27 payments — averaging $20.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$193
- AbbVie$114
- Intuitive Surgical$99
- Pfizer$53
- Merck$53
- Organogenesis Inc.$31
Across 834 payments — averaging $15,289 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$2.2M
- Astrazeneca UK Limited$2.1M
- Coherus Oncology, Inc.$1.2M
- Eli Lilly$1.2M
- Amgen$979K
- AstraZeneca$884K
- plus $4.2M from 21 others
What the payments were for
- Food & beverage$543100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 10 | $193 |
| AbbVie | 8 | $114 |
| Intuitive Surgical | 2 | $99 |
| Pfizer | 3 | $53 |
| Merck | 3 | $53 |
| Organogenesis Inc. | 1 | $31 |
How this compares
$543 in reported general payments places this provider in the 55th percentile of 1,533 internal medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Anniston
- Ryan WeldonBirmingham$458K
- Thomas McKelveyMobile$365K
- Mary HonkanenMobile$302K
- Robert LewisBirmingham$187K
- Rosalind BowlesGadsden$168K
- Sonja PettusJasper$117K
- Bobby WrightsMobile$89K
- Thomas HuddleBirmingham$76K
- Rahel AzizMobile$67K
- Justin HoveyDothan$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.